News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
290,950 Results
Type
Article (12463)
Company Profile (41)
Press Release (278446)
Section
Business (84158)
Career Advice (475)
Deals (17636)
Drug Delivery (29)
Drug Development (41086)
Employer Resources (34)
FDA (7986)
Job Trends (6595)
News (153175)
Policy (14889)
Tag
Academia (1100)
Alliances (21688)
Alzheimer's disease (669)
Approvals (7983)
Artificial intelligence (71)
Bankruptcy (158)
Best Places to Work (5617)
Breast cancer (95)
Cancer (823)
Cardiovascular disease (56)
Career advice (423)
CAR-T (58)
Cell therapy (160)
Clinical research (33497)
Collaboration (241)
Compensation (49)
COVID-19 (1087)
C-suite (50)
Data (936)
Diabetes (77)
Diagnostics (4193)
Earnings (37043)
Events (37123)
Executive appointments (180)
FDA (8369)
Funding (187)
Gene therapy (98)
GLP-1 (205)
Government (1781)
Healthcare (7663)
Infectious disease (1135)
Inflammatory bowel disease (53)
Interviews (68)
IPO (8628)
Job creations (1245)
Job search strategy (378)
Layoffs (60)
Legal (2852)
Lung cancer (110)
Lymphoma (58)
Manufacturing (97)
Medical device (5466)
Medtech (5467)
Mergers & acquisitions (9158)
Metabolic disorders (192)
Neuroscience (797)
NextGen Class of 2024 (2125)
Non-profit (1176)
Northern California (909)
Obesity (106)
Opinion (76)
Patents (69)
People (21179)
Phase I (10608)
Phase II (14637)
Phase III (11142)
Pipeline (360)
Postmarket research (1041)
Preclinical (4261)
Radiopharmaceuticals (132)
Rare diseases (119)
Real estate (2653)
Regulatory (10959)
Research institute (1006)
Resumes & cover letters (56)
Southern California (781)
Startups (1156)
United States (7920)
Vaccines (152)
Weight loss (65)
Date
Last 7 days (325)
Last 30 days (1255)
Last 365 days (19139)
2024 (19043)
2023 (21883)
2022 (27454)
2021 (28920)
2020 (27177)
2019 (18617)
2018 (13913)
2017 (14887)
2016 (13283)
2015 (15617)
2014 (11340)
2013 (9048)
2012 (9329)
2011 (10109)
2010 (9209)
Location
Africa (264)
Arizona (45)
Asia (20976)
Australia (5211)
California (2004)
Canada (879)
China (148)
Colorado (85)
Connecticut (112)
Europe (37021)
Florida (283)
Georgia (47)
Illinois (150)
Indiana (107)
Japan (54)
Maryland (291)
Massachusetts (1499)
Michigan (80)
Minnesota (93)
New Jersey (701)
New York (651)
North Carolina (375)
Northern California (909)
Ohio (65)
Pennsylvania (492)
South America (438)
Southern California (781)
Texas (319)
Utah (55)
Washington State (286)
290,950 Results for "ranbaxy laboratories limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dynavax Adopts Limited-Duration Stockholder Rights Plan
October 30, 2024
·
5 min read
Policy
Pfizer Settles Lipitor Antitrust Suit for $93M, Ends Decade-Long Court Battle
Pfizer plans to settle a lawsuit filed 12 years ago by distributors of Lipitor for $93 million. The pharma giant was accused of colluding with Ranbaxy Laboratories to delay generic versions of the drug.
February 16, 2024
·
2 min read
·
Tyler Patchen
Aurigene Pharmaceutical Services Limited, a global CRDMO, announces the opening of its biologics facility offering process development and clinical scale manufacturing capabilities
Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley
June 3, 2024
·
4 min read
Press Releases
Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India
October 9, 2024
·
8 min read
Press Releases
IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
December 5, 2024
·
19 min read
Press Releases
On Target Laboratories Appoints Bill Peters as CEO
December 11, 2024
·
3 min read
Press Releases
Meet Gaelic Laboratories, your trusted testing and manufacturing partner
11 July 2024: Gaelic Laboratories unveils its new website today, launching an upgraded and expanded laboratory technology base for advanced analytical testing, and a newly re-fitted Beta-Lactam manufacturing facility, using the latest state-of-the art technology.
July 11, 2024
·
2 min read
Deals
US BioTek Laboratories Expands Diagnostic Testing Portfolio with Acquisition of RealTime Laboratories
US BioTek Laboratories (“US BioTek”), a Clinical Laboratory Improvement Amendments (CLIA) and CAP accredited laboratory, announces the acquisition of Dallas, TX-based RealTime Laboratories (“RealTime”), a pioneer in the field of mycotoxin testing.
March 19, 2024
·
2 min read
Drug Development
IMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placebo
Positive results from the ADRIATIC Phase III trial showed AstraZeneca’s IMFINZI® demonstrated statistically significant and clinically meaningful improvements in the dual primary endpoints of overall survival and progression-free survival compared to placebo for patients with limited-stage small cell lung cancer who had not progressed following standard-of-care concurrent chemoradiotherapy.
June 2, 2024
·
27 min read
Press Releases
AV Laboratories Announces Participation in the 2025 ICR Conference
December 16, 2024
·
2 min read
1 of 29,095
Next